Development
Tharimmune, Inc.
THAR
$1.51
-$0.0001-0.01%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.54M | 1.36M | 1.33M | 1.67M | 1.08M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.53M | 1.85M | 2.36M | 2.71M | 1.77M |
| Operating Income | -2.53M | -1.85M | -2.36M | -2.71M | -1.77M |
| Income Before Tax | -2.47M | -1.82M | -2.34M | -2.69M | -1.77M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.47M | -1.82M | -2.34M | -2.69M | -1.77M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.47M | -1.82M | -2.34M | -2.69M | -1.77M |
| EBIT | -2.53M | -1.85M | -2.36M | -2.71M | -1.77M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.71 | -2.63 | -3.91 | -5.84 | -3.83 |
| Normalized Basic EPS | -0.45 | -1.64 | -2.44 | -3.65 | -2.40 |
| EPS Diluted | -0.71 | -2.63 | -3.91 | -5.84 | -3.83 |
| Normalized Diluted EPS | -0.45 | -1.64 | -2.44 | -3.65 | -2.40 |
| Average Basic Shares Outstanding | 3.47M | 691.80K | 598.00K | 460.60K | 461.00K |
| Average Diluted Shares Outstanding | 3.47M | 691.80K | 598.00K | 460.60K | 461.00K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |